Gregory Fox, PhD, MIPH, FRACP, MBBS, BSc(Med), GAICD

home / authors / gregory-fox-phd-miph-fracp-mbbs-bsc-med-gaicd

Interim Director of the Sydney Southeast Asia Centre, Professor of Respiratory Medicine at the NHMRC Clinical Trials Centre, and Research Leader at the Woolcock Institute of Medical Research

Articles

Levofloxacin for Preventing Multidrug-Resistant Tuberculosis

Levofloxacin for Preventing Multidrug-Resistant Tuberculosis

Sophia Abene;Gregory Fox, PhD, MIPH, FRACP, MBBS, BSc(Med), GAICD
January 30th 2025

Gregory Fox, PhD discusses the V Quinn trial's results, exploring levofloxacin’s role in reducing TB incidence and the study's approach to combining data with the TB Champ trial.

Read More

Latest Updated Articles

Concerns Over Mosquito-Borne Illness Causes Massachusetts Town to Create Curfew for Parks, Spraying in Counties
Published: August 27th 2024 | Updated: August 28th 2024
Concerns Over Mosquito-Borne Illness Causes Massachusetts Town to Create Curfew for Parks, Spraying in Counties
Fungal Infections: Invisible Until It’s Too Late
Published: January 24th 2025 | Updated: January 31st 2025
Fungal Infections: Invisible Until It’s Too Late
Echinocandin Dosing Considerations in Obese Patients: A Review
Published: November 18th 2024 | Updated: November 18th 2024
Echinocandin Dosing Considerations in Obese Patients: A Review
Dusty Fungal Threat: Valley Fever Spreads as Conditions Change
Published: January 24th 2025 | Updated: January 31st 2025
Dusty Fungal Threat: Valley Fever Spreads as Conditions Change
Fungal Infection Diagnosis, Misdiagnoses, and Global Health Initiatives
Published: January 27th 2025 | Updated: January 31st 2025
Fungal Infection Diagnosis, Misdiagnoses, and Global Health Initiatives
Immune Deficits in Some Valley Fever Patients Hinder Response to Antifungal Treatment
Published: January 28th 2025 | Updated: January 31st 2025
Immune Deficits in Some Valley Fever Patients Hinder Response to Antifungal Treatment
© 2025 MJH Life Sciences

All rights reserved.